Treatment of Kawasaki Syndrome

Abstract
Mucocutaneous lymph node syndrome (Kawasaki syndrome) is an acute febrile syndrome of unknown origin recognized predominantly in children under nine years of age. The disease was first recognized as a clinical entity in Japan in 1961, by Tomisaku Kawasaki, who reported it in 1967.1 However, Kawasaki syndrome has now been recognized throughout the world. Local geographic and temporal clustering of cases has been reported frequently.Because the first cases were seen in Japanese children and American children of predominantly Japanese background, Kawasaki syndrome was initially presumed to occur most commonly in the Japanese. That assumption has not been disproved. The . . .

This publication has 4 references indexed in Scilit: